386 related articles for article (PubMed ID: 31838163)
21. Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study.
Sambataro G; Libra A; Spicuzza L; Palmucci S; Conti P; Spagnolo E; Colaci M; Malatino L; Orlandi M; Sambataro D; Vancheri C
Respiration; 2023; 102(6):405-415. PubMed ID: 37231870
[TBL] [Abstract][Full Text] [Related]
22. Clinical and HRCT features of amyopathic dermatomyositis associated with interstitial lung disease: A retrospective study of 128 patients with connective tissue disease-related interstitial lung disease.
Wu T; Zhou H; Xu S; Deng Z; Zhang Y; Ding Q
Am J Med Sci; 2023 May; 365(5):429-436. PubMed ID: 36521530
[TBL] [Abstract][Full Text] [Related]
23. Rituximab for the treatment of connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis.
Xu L; Wang F; Luo F
Front Pharmacol; 2022; 13():1019915. PubMed ID: 36386239
[No Abstract] [Full Text] [Related]
24. Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis.
Goswami RP; Ray A; Chatterjee M; Mukherjee A; Sircar G; Ghosh P
Rheumatology (Oxford); 2021 Feb; 60(2):557-567. PubMed ID: 33164098
[TBL] [Abstract][Full Text] [Related]
25. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
26. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
Kilinc AA; Arslan A; Yildiz M; Kucur M; Adrovic A; Barut K; Sahin S; Cokugras H; Kasapcopur O
Rheumatol Int; 2020 Oct; 40(10):1701-1706. PubMed ID: 31784789
[TBL] [Abstract][Full Text] [Related]
27. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.
Koo SM; Uh ST
Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913
[TBL] [Abstract][Full Text] [Related]
28. Management of interstitial lung disease associated with connective tissue disease.
Mathai SC; Danoff SK
BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
[TBL] [Abstract][Full Text] [Related]
29. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis.
Joy GM; Arbiv OA; Wong CK; Lok SD; Adderley NA; Dobosz KM; Johannson KA; Ryerson CJ
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36889782
[TBL] [Abstract][Full Text] [Related]
31. Connective tissue disease-associated interstitial lung disease.
Oliveira RP; Ribeiro R; Melo L; Grima B; Oliveira S; Alves JD
Pulmonology; 2022; 28(2):113-118. PubMed ID: 32044296
[TBL] [Abstract][Full Text] [Related]
32. Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.
Doyle TJ; Dhillon N; Madan R; Cabral F; Fletcher EA; Koontz DC; Aggarwal R; Osorio JC; Rosas IO; Oddis CV; Dellaripa PF
J Rheumatol; 2018 Jun; 45(6):841-850. PubMed ID: 29606668
[TBL] [Abstract][Full Text] [Related]
33. Effects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease.
Benad M; Koschel D; Herrmann K; Wiefel K; Kleymann A; Aringer M
Clin Exp Rheumatol; 2022 Mar; 40(3):483-488. PubMed ID: 33635231
[TBL] [Abstract][Full Text] [Related]
34. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.
Wallace B; Vummidi D; Khanna D
Curr Opin Rheumatol; 2016 May; 28(3):236-45. PubMed ID: 27027811
[TBL] [Abstract][Full Text] [Related]
35. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review.
Atzeni F; Gerardi MC; Barilaro G; Masala IF; Benucci M; Sarzi-Puttini P
Expert Rev Clin Immunol; 2018 Jan; 14(1):69-82. PubMed ID: 29202589
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.
Vij R; Strek ME
Chest; 2013 Mar; 143(3):814-824. PubMed ID: 23460159
[TBL] [Abstract][Full Text] [Related]
37. Effects of rituximab in connective tissue disorders related interstitial lung disease.
Lepri G; Avouac J; Airò P; Anguita Santos F; Bellando-Randone S; Blagojevic J; Garcia Hernàndez F; Gonzalez Nieto JA; Guiducci S; Jordan S; Limaye V; Maurer B; Selva-O'Callaghan A; Riccieri V; Distler O; Matucci-Cerinic M; Allanore Y
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):181-185. PubMed ID: 27749242
[TBL] [Abstract][Full Text] [Related]
38. The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies.
Tseng CC; Sung YW; Chen KY; Wang PY; Yen CY; Sung WY; Wu CC; Ou TT; Tsai WC; Liao WT; Chen CJ; Lee SC; Chang SJ; Yen JH
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569370
[TBL] [Abstract][Full Text] [Related]
39. Connective tissue disease-related interstitial lung disease.
Demoruelle MK; Mittoo S; Solomon JJ
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):39-52. PubMed ID: 27421215
[TBL] [Abstract][Full Text] [Related]
40. Interstitial lung disease in connective tissue disorders.
Fischer A; du Bois R
Lancet; 2012 Aug; 380(9842):689-98. PubMed ID: 22901890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
